AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

NIH Scientists Discover How HIV Kills Immune Cells

NIAID

FOR IMMEDIATE RELEASE Wednesday, June 5, 2013 MEDIA AVAILABILITY NIH Scientists Discover How HIV Kills Immune Cells Findings Have Implications for HIV Treatment WHAT: Untreated HIV infection destroys a person’s immune system by killing infection-fighting cells, but precisely when and how HIV wreaks this destruction has been a mystery until now. New research by scientists…

Hepatitis C Infection Among Young Injection Drug Users: Addressing an Emerging Trend

Hepatitis C Report Cover

In recent years, there has been an emerging epidemic of hepatitis C virus (HCV) infection among young injection drug users (IDU) in rural and suburban settings. Early this spring, the U.S. Department of Health and Human Services convened a multidisciplinary technical consultation to discuss the existing evidence and to identify and define priorities for the…

HIV Vaccine Research Update and HVTN 505

HVAD Logo

May 18th was HIV Vaccine Awareness Day, and we wanted to remind you of several posts we did last week on that subject. On Friday, we featured a guest post, Moving Forward on HIV Vaccine Awareness Day, by Dr. Nelson Michael, director of the U.S. Military HIV Research Program. And then we posted this video…

May 18th HIV Vaccine Awareness Day (HVAD): A Conversation with Dr. Carl Dieffenbach

HVAD Logo

May 18th is HIV Vaccine Awareness Day (HVAD), led by the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. We spoke to Dr. Carl Dieffenbach at NIH, who had this to say about HIV Vaccine Awareness Day: “[On Vaccine Awareness Day] we can take a moment to acknowledge the…

Statement: NIH Discontinues Immunizations in HIV Vaccine Study

NIAID

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, will stop administering injections in its HVTN 505 clinical trial of an investigational HIV vaccine regimen because an independent data and safety monitoring board (DSMB) found during a scheduled interim review that the vaccine regimen did not prevent HIV infection nor…

Daily-use HIV Prevention Approaches Didn’t Work for African Women in the VOICE Study

blog.aids.gov

According to findings of a major HIV prevention trial presented Monday, March 4, 2013 at the 20th Conference on Retroviruses and Opportunistic Infections (CROI), study participants who received daily oral pre-exposure prophylaxis (PrEP) did not experience any protection against HIV compared to those in the placebo arm, likely because very few were taking the study…

Toddler ‘Functionally Cured’ of HIV Infection, NIH-Supported Investigators Report

Dr. Persaud NIH

Discovery Provides Clues for Potentially Eliminating HIV Infection in Other Children Editor’s note: NIH issued this news release this afternoon about findings announced at the 2013 Conference on Retroviruses and Opportunistic Infections (CROI) which began today in Atlanta, Georgia. The session at which the investigators will be reporting their findings in detail will be webcast…

Apps and Social Media to Show You Care

Listen:

Javascript and flash are required to play this audio file.

Download MP3
Heart phone

Social media and mobile apps are great tools to help you connect to people. For example, you can connect to your former high school sweetheart on Facebook, share photos with your family on Instagram, send an eCard to your partner, or tweet about the great date you had last night. You also can use apps…

Page 1 of 111234...10...Last »